- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07760116
Robotic Exoskeleton Gait Training With and Without Brain-Computer Interface Control After Stroke
Comparison of the Therapeutic Effects Between Traditional and Brain-Computer Interface-Controlled Exoskeleton Gait Training in Post-Stroke Patients: A Randomized Comparative Study
After a stroke, many people have trouble walking. One way to practice walking again is with a wearable robot, called an exoskeleton, that supports the legs and guides them through a walking pattern. In most systems, a therapist or a sensor decides when each step starts.
This study looked at whether it helps to let a person's own brain activity start each step instead. Sensors placed on the scalp recorded brain signals. A computer read these signals and told the robot when to take a step. This way of controlling a device is called a brain-computer interface.
People who had a stroke within the past year took part. They were placed by chance into one of two groups. One group practiced walking with the robot in the usual way. The other group practiced with the robot controlled by their own brain signals. Both groups trained twice a week for 4 weeks.
Before and after the training, the study team measured how far each person could walk in 6 minutes, how long it took to stand up and walk a short distance and sit down again, how strong the knee muscles were, and how each person rated their own health and well-being. The study compared how much the two groups improved.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Taichung, Taïwan, 407219
- Taichung Veterans General Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 30 to 80 years
- Unilateral lower-limb weakness attributable to a stroke sustained within the previous year
- Able to complete the Timed Up and Go (TUG) test at baseline
- Able to follow training instructions
- Provided written informed consent
Exclusion Criteria:
- Baseline Timed Up and Go (TUG) time of less than 20 seconds
- Significant pain in the lower limbs
- Prior lower-limb surgery
- Neuromuscular disease affecting gait
- Cardiopulmonary condition contraindicating gait training
- Cognitive or cooperative deficits preventing the participant from following training instructions
- Inability to perform the Timed Up and Go (TUG) test at baseline
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Conventionnel
|
Powered lower-limb exoskeleton gait training, twice weekly for 4 weeks.
Each session included sit-to-stand, walking, and stand-to-sit phases.
Phase transitions were triggered externally by a trained study assistant.
No EEG decoding was used.
|
|
Expérimental: BCI-Controlled
|
Same exoskeleton training schedule and phases.
Each session began with a 6-minute EEG decoder calibration (theta, movement-related cortical potential, alpha).
Each phase transition was triggered in a closed loop by the participant's decoded intent.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in 6-Minute Walk Test (6MWT) distance
Délai: Baseline and 4 weeks (immediately before and after the 4-week training program)
|
Distance walked in 6 minutes along a flat 30-meter indoor corridor, recorded in meters.
Participants were instructed to cover as much distance as possible.
The same corridor was used for all assessments at both time points.
Greater distance indicates better walking capacity.
|
Baseline and 4 weeks (immediately before and after the 4-week training program)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in SF-12 Physical Component Summary (PCS) score
Délai: Baseline and 4 weeks (immediately before and after the 4-week training program)
|
Physical component summary score of the 12-item Short Form Health Survey.
Scores are norm-based to a population mean of 50 with a standard deviation of 10.
Higher scores indicate better physical health-related quality of life.
|
Baseline and 4 weeks (immediately before and after the 4-week training program)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Troubles cérébrovasculaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Maladies vasculaires
- Maladies cardiovasculaires
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Accident vasculaire cérébral
- Parésie
- Troubles de la marche, neurologiques
Autres numéros d'identification d'étude
- CF21277A-1
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .